Site access drives cost-effectiveness of TAVR, study finds

11/12/2012 | TCTMD.com

The cost-effectiveness of transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis is access-site dependent, according to an analysis of the PARTNER trial published in the Journal of the American College of Cardiology. The findings support the transfemoral route, which demonstrated similar overall costs to surgery but shorter stays in the ICU and hospital overall and shorter procedural time.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID